International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
The Growing Influence of the Institute of Clinical and… 11/21/2019
Medical Diagnostics: leveraging new opportunities from AI… 01/16/2020